I agree. Q2 earnings from cont. operations of .22/share vs. .01/share last year. On the CC, they said the nonrecurring expense to SG&A was $180,000. Also looks like there was a $40,579 gain on an asset sale. Earnings more like .26/share if you factor in those 2 items.

Stock would be attractive here on that alone, but check out the Q2 CC transcript:

http://seekingalpha.com/article/156913-m...

Some very bullish comments. They think Q3 bookings could be a record (although timing can be difficult to predict). In the Q&A, they state the backlog at the end of the quarter could be 20% above last year. Considering they had a $20.5M backlog at the end of Q2 and a $21M backlog at the end of Q3 last year, that would suggest huge bookings in Q3!

On the CC, they're also anticipating a strong operating performance in Q3. Gross margins have been improving, and SG&A looks to remain fairly constant. Only bad thing is it appears the tax rate will be going up to normal. Still think if Q3 revenues come in at $9-$10M, they could post earnings of .30+/share. With only 3M shares O/S, could turn into a low float rocket if the market is still hot.